tldrdaily.news logo
Tag

2025 Results

All articles tagged with #2025 results

Stellantis resets strategy after 2025 losses, targeting growth in 2026
business3 days ago

Stellantis resets strategy after 2025 losses, targeting growth in 2026

Stellantis posted full-year 2025 net revenues of €153.5 billion (−2% vs 2024) and a net loss of €22.3 billion, driven by €25.4 billion in unusual charges tied to a strategic reset to prioritize customer choice. Adjusted operating income was −€0.842 billion (AOI margin −0.5%), and industrial free cash flow was −€4.525 billion. The second half showed improvement, with 10% revenue growth and a reduced IFCF loss. For 2026 the company reiterates guidance for mid‑single‑digit net revenue growth, low‑single‑digit AOI margin, and improved IFCF (including €2 billion in 2026 payments related to H2 2025 charges), suspends the 2026 dividend, and plans up to €5 billion of hybrid bonds to bolster liquidity as it expands a broad product wave across regions toward profitable growth (with the aim of positive IFCF in 2027).

via Stellantis.com|
#2025-results#automotive#business
Coca‑Cola Sees 2025 Finish Strong, Maps Bold Path for 2026
business19 days ago

Coca‑Cola Sees 2025 Finish Strong, Maps Bold Path for 2026

Coca-Cola reported Q4 2025 net revenues of $11.8B (up 2% y/y) and full-year net revenues of $47.9B (up 2%), with organic revenues up 5% in both periods. Q4 operating margin was 15.6% (comparable 24.4%); full-year margin was 28.7% (comparable 31.2%). Q4 EPS rose 4% to $0.53 (comparable $0.58); full-year EPS rose 23% to $3.04 (comparable $3.00). Cash flow from operations for 2025 was $7.4B, with free cash flow of $5.3B (or $11.4B excluding the fairlife contingent payment). For 2026, the company guides organic revenue growth of 4–5% with about a 1% currency tailwind and roughly a 4% headwind from acquisitions/divestitures, aiming for about $12.2B in free cash flow, while continuing strategic investments and maintaining its dividend and share repurchase program.

via investors.coca-colacompany.com|
#2025-results#business#coca-cola
Stellantis Reorients Strategy Around Customer Choice to Drive Profitability
business22 days ago

Stellantis Reorients Strategy Around Customer Choice to Drive Profitability

Stellantis unveiled a strategic reset to align its portfolio with real-world customer demand for EVs, hybrids and ICE, taking about €22.2 billion in charges in H2 2025 (including roughly €6.5 billion cash) and suspending the 2026 dividend as it issues up to €5 billion of hybrid bonds; it also plans a roughly $13 billion U.S. investment, new models and a major reorganization to restore growth and improve net revenues, AOI margin and industrial free cash flow in 2026, supported by about €46 billion in industrial liquidity. Early results show H2 2025 volume rose 11% to 2.8 million units with higher orders and improved quality, while 2025 ends in a net loss before the planned improvements take hold.

via Stellantis.com|
#2025-results#business#ev-strategy
Abbott posts strong 2025 earnings, outlines 2026 growth plan and strategic moves
business1 month ago

Abbott posts strong 2025 earnings, outlines 2026 growth plan and strategic moves

Abbott reported Q4 2025 GAAP EPS of $1.01 and adjusted EPS of $1.50 (up 12%), and full-year 2025 sales of $44.3B with adjusted EPS of $5.15 (up 10%). For 2026, it guides organic sales growth of 6.5%–7.5% and adjusted EPS of $5.55–$5.80 (about 10% at the midpoint). The company also plans to close its Exact Sciences acquisition in Q2 2026 to expand cancer diagnostics, announced regulatory advances in electrophysiology and ablation, and declared a quarterly dividend of $0.63.

via Abbott MediaRoom|
#2025-results#2026-outlook#abbott
CVS Surges on Strong Q2 Earnings and Improved Outlook
business7 months ago

CVS Surges on Strong Q2 Earnings and Improved Outlook

CVS Health reported an 8.4% increase in Q2 2025 revenues to $98.9 billion, with adjusted EPS of $1.81, and revised full-year guidance to reflect strong performance in healthcare benefits and pharmacy segments, despite some declines in health services. The company emphasizes its focus on providing a connected, simpler healthcare experience and continues to execute strategic initiatives to create long-term value.

via CVS Health|
#2025-results#business#cvs-health